Researcher.Life Logo

Bleeding, Thrombosis and Vascular Biology : Impact Factor & More

eISSN: 2785-5309
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Bleeding, Thrombosis and Vascular Biology Journal Specifications

Indexed in the following public directories

  • DOAJ DOAJ
Overview
Publisher PAGEPress Publications
Language English
Publication Time14
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorSISET Società Italiana per lo Studio dell'Emostasi e Trombosi
Website URLVisit website
Publication Details
Publication Time 14
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Bleeding, Thrombosis and Vascular Biology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Bleeding, Thrombosis and Vascular Biology

PO10 | RISK OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS WITH CENTRAL VENOUS CATHETERS: RESULTS FROM THE VIENNA CAT-BLED STUDY
  • 16 Apr 2026
  • Bleeding, Thrombosis and Vascular Biology
PO54 | CANCER-ASSOCIATED THROMBOSIS IN ASPIRIN-TREATED PATIENTS AFTER ARTERIAL THROMBOSIS: THE COMPASS-ARTECAT-ASA PROSPECTIVE COHORT STUDY
  • 16 Apr 2026
  • Bleeding, Thrombosis and Vascular Biology
Neurovascular protective effects of nutritional interventions in ischemic brain injury
  • 10 Apr 2026
  • Bleeding, Thrombosis and Vascular Biology
Bleeding complications of oral anticoagulant therapy: from ISCOAT to the START Register
  • 10 Apr 2026
  • Bleeding, Thrombosis and Vascular Biology
Cardiovascular risk in hormone replacement therapy
  • 9 Feb 2026
  • Bleeding, Thrombosis and Vascular Biology
Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers
  • 26 Jan 2026
  • Bleeding, Thrombosis and Vascular Biology
PO10 | RISK OF VENOUS THROMBOEMBOLISM IN CANCER PATIENTS WITH CENTRAL VENOUS CATHETERS: RESULTS FROM THE VIENNA CAT-BLED STUDY
  • 16 Apr 2026
  • Bleeding, Thrombosis and Vascular Biology
PO54 | CANCER-ASSOCIATED THROMBOSIS IN ASPIRIN-TREATED PATIENTS AFTER ARTERIAL THROMBOSIS: THE COMPASS-ARTECAT-ASA PROSPECTIVE COHORT STUDY
  • 16 Apr 2026
  • Bleeding, Thrombosis and Vascular Biology
Neurovascular protective effects of nutritional interventions in ischemic brain injury
  • 10 Apr 2026
  • Bleeding, Thrombosis and Vascular Biology
Bleeding complications of oral anticoagulant therapy: from ISCOAT to the START Register
  • 10 Apr 2026
  • Bleeding, Thrombosis and Vascular Biology
Cardiovascular risk in hormone replacement therapy
  • 9 Feb 2026
  • Bleeding, Thrombosis and Vascular Biology
Bioequivalence of von Willebrand factor-containing concentrates: implications for the choice in patients with von Willebrand disease. A position paper from the Italian Association of Hemophilia Centers
  • 26 Jan 2026
  • Bleeding, Thrombosis and Vascular Biology

FAQs on Bleeding, Thrombosis and Vascular Biology